Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy - Test2 - elhamkhani - TriplyDB

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy

http://www.wikidata.org/entity/Q24701766

about

Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion Chikungunya vaccines in development A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.Generation of Recombinant Monoclonal Antibodies from Immunised Mice and Rabbits via Flow Cytometry and Sorting of Antigen-Specific IgG+ Memory B Cells.Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.Chikungunya Virus.Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.A Biologically-validated HCV E1E2 Heterodimer Structural Model.High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.Current Strategies for Inhibition of Chikungunya Infection.Cellular and Molecular Immune Response to Chikungunya Virus Infection

P2860

Q24701760-3BC61612-A7B4-4264-A751-ECA4791952C5 Q26700081-C3AF9E61-50A0-49BB-8C27-846CDD42A1BE Q26700129-07B57384-1266-40ED-A618-63168F53347F Q27468808-6594F104-129D-40F4-8EF4-BAB10F149F23 Q27728106-56AE1813-524A-4C18-9D3A-D68F02492DD3 Q28552644-C6BD9DB8-3B86-4A87-9536-EE8D0C70AB35 Q35850197-6F0527A3-9C8E-4C02-A8B8-1FFC42E284B9 Q35972482-90FBFC45-A06B-4257-A761-F500EFF4CC56 Q36169170-8B80FF34-DC48-4709-B481-B2355A62A543 Q36208191-C3CEB992-7C27-48A8-8A1B-046D190A1628 Q36300209-8CDA55A7-4BD7-4462-864E-408D9589C2A2 Q36318652-3C364C52-D2DF-46FE-AADD-04A793606F49 Q36483436-4D8B995D-CF15-4CDB-BA79-DFAABA8CF447 Q37141597-A2584B24-8709-48E3-9340-25A3EDFD1CED Q39013750-F338B2AB-F4D1-4A4E-8DE9-EAD4F27B1C13 Q39273197-DCD5BB87-6263-4D08-844D-F94CEFDBA534 Q40052932-509385AB-1F7F-4727-ADAE-661139D6F636 Q40077669-47E2EA74-BE44-4D96-98D4-32696A3E0F26 Q40288437-CD90E361-8821-40CF-896A-440688B970A1 Q46272894-6E8C1037-1EC9-4B63-823B-EA6144120B79 Q54214355-B9B015F3-A490-45D1-936B-FD36FBB1AD8C Q58575620-2088D644-15BB-4173-ABCF-6740611D0717

P2860

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy

http://www.wikidata.org/entity/Q24701766

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Exposure of epitope residues o ...... antibody neutralizing efficacy

@ast

Exposure of epitope residues o ...... antibody neutralizing efficacy

@en

Exposure of epitope residues o ...... antibody neutralizing efficacy

@nl

type

label

Exposure of epitope residues o ...... antibody neutralizing efficacy

@ast

Exposure of epitope residues o ...... antibody neutralizing efficacy

@en

Exposure of epitope residues o ...... antibody neutralizing efficacy

@nl

prefLabel

Exposure of epitope residues o ...... antibody neutralizing efficacy

@ast

Exposure of epitope residues o ...... antibody neutralizing efficacy

@en

Exposure of epitope residues o ...... antibody neutralizing efficacy

@nl

P1433

Q24701766-26BA7EBF-5BAB-4415-8098-EFADAD37F1FC

P1476

Q24701766-8D224330-F50C-43C5-AD4B-383C230F8E47

P2093

Q24701766-0A3FDBD5-B972-4D19-A733-48CEF4B0E9D5

Q24701766-1A467EEB-33F5-4060-B629-BAF0F1A2E3F5

Q24701766-1D76D67D-6CA7-41D9-8B59-F8B96BE65EC3

Q24701766-2224B731-379D-4895-B90F-09EDEA71A86F

Q24701766-2F16071F-54C1-40A0-BB19-113956AB1476

Q24701766-319F8A2E-A1F6-4B04-AC01-34B6E4202086

Q24701766-346224F3-DB12-4AEF-A11B-830BF5FCFFF2

Q24701766-42166C82-AAA6-42C5-A706-16DAFE609839

Q24701766-4A363688-E958-4755-9268-3401D0088AD3

Q24701766-6E832D93-3DF0-4607-9D28-60A5D6F41AA2

P2860

Q24701766-094D6BA2-A711-48A4-B56E-17BF5F014743

Q24701766-0F3EE9B1-97AB-436D-BDCD-BD4C57EF5E79

Q24701766-10F69F59-812C-42F7-A9A4-A21B0410D3FE

Q24701766-18E9F6E9-2FDE-4506-A6FF-C463419007A1

Q24701766-1EE604D4-57C7-420A-843A-546360F27DFD

Q24701766-20021477-6749-4286-96BD-C2D8D6F9A87C

Q24701766-22673978-9C06-435F-A572-D50212E6599B

Q24701766-236075CC-19E7-492A-8A29-66EAC33D4D8F

Q24701766-2F16D7AB-569E-413E-9B93-8A3C7CC0AB27

Q24701766-3354D376-595C-4876-87FD-1E6BB6661DDD

P304

Q24701766-11186ACC-882C-435A-8570-F3CE6762CD01

P31

Q24701766-40CDBEE3-DB2B-4E70-9F54-10CCA3BF064B

P3181

Q24701766-A20021E7-650F-4BE5-9216-F71F6387BB0F

P356

Q24701766-9722E2A1-7AA2-45FD-A283-7BB353408DD3

P407

Q24701766-EF822A37-6653-4D9D-B0C7-053578552369

P433

Q24701766-ECA6F51B-BB43-405A-8197-F90B5C745DA1

P478

Q24701766-3D850D89-A02F-4FA3-AB5F-BE8F8F035598

P50

Q24701766-3C4A8129-D786-4D70-8B1A-E50903B02D0D

Q24701766-8875C14B-D892-43A5-B4A5-035DAF830F35

Q24701766-B417CAD5-F22C-4721-87B2-61A5FDCB2B64

P5008

Q24701766-C664FAE7-18D4-4B83-A34A-9B5868F8DA4C

P577

Q24701766-7FCBCA3B-2166-4334-B562-A2B610721388

P5875

Q24701766-B623A7D6-8C43-4507-8640-1D66B9AAA65B

P698

Q24701766-5A61E4EE-2EF1-4BBA-8C57-08817A519323

P921

Q24701766-A9F915B0-75FE-43CE-BC5A-55ABE1F00F42

Q24701766-BE461164-C46D-42DC-84DC-546377675553

P932

Q24701766-6A0195A8-EDA0-4A45-96DB-4F973CFEA15C

P3181

P356

P1433

Journal of Virology

P1476

Exposure of epitope residues o ...... antibody neutralizing efficacy

@en

P2093

Adam Miller

http://www.w3.org/2001/XMLSchema#string

Benjamin J Doranz

http://www.w3.org/2001/XMLSchema#string

Cheryl Paes

http://www.w3.org/2001/XMLSchema#string

David Tucker

http://www.w3.org/2001/XMLSchema#string

Joseph B Rucker

http://www.w3.org/2001/XMLSchema#string

Kai Lu

http://www.w3.org/2001/XMLSchema#string

Kimberly Mattia

http://www.w3.org/2001/XMLSchema#string

Kristen M Kahle

http://www.w3.org/2001/XMLSchema#string

Manu Mabila

http://www.w3.org/2001/XMLSchema#string

Nathan Liss

http://www.w3.org/2001/XMLSchema#string

P2860

Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization

A single mutation in chikungunya virus affects vector specificity and epidemic potential

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak

Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?

Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine

Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo

Atomic-level mapping of antibody epitopes on a GPCR

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes

A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes

P304

14364-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1055845

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01943-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Marcus O. Muench

P5008

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266572704

http://www.w3.org/2001/XMLSchema#string

P698

25275138

http://www.w3.org/2001/XMLSchema#string

P921

Chikungunya virus

P932

4249124

http://www.w3.org/2001/XMLSchema#string